Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer

被引:2
作者
ChengXue Dang
Yue Han
ZhaoYin Qin
YaJun Wang From the Department of Tumor Surgery First Hospital Xian Jiaotong University Xian China [710061 ]
机构
关键词
pancreatic cancer; p21ras; p53; PCNA; immunohistochemistry;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
<正> Objective: To study the clinical significance and effectof p21, p53 protein as well as proliferating cell nuc-lear antigen (PCNA) on the occurrence and develop-ment of pancreatic carcinoma.Method: p21, p53 protein and PCNA expressionswere detected in specimens from 30 patients withpancreatic carcinoma and 3 samples of normal pan-creatic tissue by immunohistochemistry. The datawere analyzed together with clinical findings.Results: The positive expression rates of p21 and p53proteins were 75.0% and 57.3% respectively in pan-creatic carcinoma, which were significantly differentfrom those in the normal tissue (P<0.05). p21 andp53 proteins were positively correlated (P<0.05).The positive expression of PCNA was 43.33%±17.99%, that was significantly higher than that inthe normal pancreatic tissue (P<0.05). The expres-sion of PCNA was correlated with the histologicalgrade (P<0.05). The positive expression rate wasconsistent with the exacerbation of cancer. The ex-pression was also correlated significantly with prog-nosis and p53 expression (P<0.05).Conclusions: The occurrence and development ofpancreatic cancer are the result of associated functionfor many oncogenes and antioncogenes. PCNA maybe helpful to identify malignant degree and prognosisof pancreatic cancer.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 5 条
[1]  
K-ras and p53 protein mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesion. Pellegata NS,Sessa F,Renault B, et al. Cancer Research . 1991
[2]  
Liver, gallbladder, extrahepatic bile ducts, and pancreas. Carriage MT,Henson DE. Cancer . 1995
[3]  
Proliferating cell nuclear antigen labeling index of preoperative specimens in gastric carcinoma with special reference to prognosis. Maeda K,Chung Ys,Onoda N,et al. Cancer . 1994
[4]  
Expression of p53 gene mutation in colorectal cancer and its relationship to short-term prognosis. Yamaguchi A,Kurosaka Y,Fushida S, et al. Cancer . 1992
[5]  
Pancreatic cancer in Europe: K-ras gene mutation pattern shows geographical differences. Scarpa A,Capelli P,Villanuera A, et al. International Journal of Cancer . 1994